The Efficacy and Safety of Docetaxel Combined With Platinum for Metastatic Hormone-sensitive Prostate Cancer

Clinical trial NCT05461261 · UNKNOWN

Trial details

NCT number: NCT05461261
Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Hormone Sensitive Metastatic Prostate Cancer DNA Damage Repair Deficiency Chemotherapy Effect Chemotherapeutic Toxicity

Start date: 2022-07-01
Primary completion: 2025-06-30
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.